Seattle Genetics to Present at RBC Capital Markets 2019 Global Healthcare Conference
May 15 2019 - 8:00AM
Business Wire
Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that
management will present at the RBC Capital Markets 2019 Global
Healthcare Conference on Wednesday, May 22, 2019 at 8:30 a.m.
Eastern Time. The presentation will be webcast live and available
for replay from Seattle Genetics’ website at
www.seattlegenetics.com in the Investors section.
About Seattle Genetics
Seattle Genetics, Inc. is an emerging multi-product, global
biotechnology company that develops and commercializes
transformative therapies targeting cancer to make a meaningful
difference in people’s lives. ADCETRIS® (brentuximab vedotin)
utilizes the company’s industry-leading antibody-drug conjugate
(ADC) technology and is currently approved for the treatment of
multiple CD30-expressing lymphomas. Beyond ADCETRIS, the company
has established a pipeline of novel targeted therapies at various
stages of clinical testing, including three in ongoing pivotal
trials for solid tumors. Enfortumab vedotin for metastatic
urothelial cancer and tisotumab vedotin for metastatic cervical
cancer utilize our proprietary ADC technology. Tucatinib, a small
molecule tyrosine kinase inhibitor, is in a pivotal trial for
HER2-positive metastatic breast cancer. In addition, we are
leveraging our expertise in empowered antibodies to build a
portfolio of proprietary immuno-oncology agents in clinical trials
targeting hematologic malignancies and solid tumors. The company is
headquartered in Bothell, Washington, and has a European
office in Switzerland. For more information on our robust
pipeline, visit www.seattlegenetics.com and follow
@SeattleGenetics on Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190515005184/en/
Investors:Peggy Pinkston(425) 527-4160ppinkston@seagen.com
Media:Monique Greer(425) 527-4641mgreer@seagen.com
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024